# Evolv Technologies Holdings, Inc.: overview

EVLV · Nasdaq · CIK 1805385 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/evlv.md) · [Financials](/companies/evlv/financials.md) · [Filings](/companies/evlv/filings.md) · [Insiders](/companies/evlv/insiders.md)

Latest reported revenue: [$43.8m](/filings/0001805385-26-000049.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 11, 2026 (XBRL us-gaap:Revenues, accession 0001805385-26-000049).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [27.4](/filings/0001805385-25-000017.md) | [29.1](/filings/0001628280-25-020355.md) | [32.0](/filings/0001805385-26-000028.md) | [32.5](/filings/0001805385-26-000049.md) | [42.9](/filings/0001805385-25-000017.md) | [38.5 d](/filings/0001805385-26-000012.md) | [46.3](/filings/0001805385-26-000028.md) | [43.8](/filings/0001805385-26-000049.md) |
| Gross margin | % | [57.8%](/filings/0001805385-25-000017.md) | [57.5%](/filings/0001628280-25-020355.md) | [59.8%](/filings/0001805385-26-000028.md) | [49.8%](/filings/0001805385-26-000049.md) | [49.7%](/filings/0001805385-25-000017.md) | [48.4% d](/filings/0001805385-26-000012.md) | [50.9%](/filings/0001805385-26-000028.md) | [50.2%](/filings/0001805385-26-000049.md) |
| Operating margin | % | [(70.0%)](/filings/0001805385-25-000017.md) | [(64.9%)](/filings/0001628280-25-020355.md) | [(45.0%)](/filings/0001805385-26-000028.md) | [(53.8%)](/filings/0001805385-26-000049.md) | [(20.1%)](/filings/0001805385-25-000017.md) | [(20.7%) d](/filings/0001805385-26-000012.md) | [(18.3%)](/filings/0001805385-26-000028.md) | [(24.1%)](/filings/0001805385-26-000049.md) |
| Net margin | % | [(111.3%)](/filings/0001805385-25-000017.md) | [(54.0%)](/filings/0001628280-25-020355.md) | [(5.3%)](/filings/0001805385-26-000049.md) | [(124.6%)](/filings/0001805385-26-000049.md) | [(4.2%)](/filings/0001805385-25-000017.md) | [28.3% d](/filings/0001805385-26-000012.md) | [(10.8%)](/filings/0001805385-26-000049.md) | [(21.3%)](/filings/0001805385-26-000049.md) |
| Diluted EPS | $ per share | [(0.19)](/filings/0001805385-25-000017.md) | not reported | [(0.01)](/filings/0001805385-26-000028.md) | [(0.25)](/filings/0001805385-26-000049.md) | [(0.01)](/filings/0001805385-25-000017.md) | not reported | [(0.03)](/filings/0001805385-26-000028.md) | [(0.05)](/filings/0001805385-26-000049.md) |
| Free cash flow | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [23.4](/filings/0001628280-23-009178.md) | [52.7](/filings/0001628280-25-020355.md) | [79.6](/filings/0001628280-25-020355.md) | [104](/filings/0001805385-26-000012.md) | [146](/filings/0001805385-26-000012.md) |
| Gross margin | % | [17.2%](/filings/0001628280-23-009178.md) | [2.7%](/filings/0001628280-25-020355.md) | [40.1%](/filings/0001628280-25-020355.md) | [57.2%](/filings/0001805385-26-000012.md) | [51.6%](/filings/0001805385-26-000012.md) |
| Operating margin | % | [(236.3%)](/filings/0001628280-23-009178.md) | [(195.3%)](/filings/0001628280-25-020355.md) | [(113.2%)](/filings/0001628280-25-020355.md) | [(79.2%)](/filings/0001805385-26-000012.md) | [(33.2%)](/filings/0001805385-26-000012.md) |
| Net margin | % | [(46.5%)](/filings/0001628280-23-009178.md) | [(164.6%)](/filings/0001628280-25-020355.md) | [(135.8%)](/filings/0001628280-25-020355.md) | [(52.0%)](/filings/0001805385-26-000012.md) | [(22.7%)](/filings/0001805385-26-000012.md) |
| Diluted EPS | $ per share | [(0.15)](/filings/0001628280-23-009178.md) | [(0.60)](/filings/0001628280-25-020355.md) | [(0.72)](/filings/0001628280-25-020355.md) | [(0.34)](/filings/0001805385-26-000012.md) | [(0.20)](/filings/0001805385-26-000012.md) |
| Free cash flow | $m | [(73.3)](/filings/0001628280-23-009178.md) | not reported | not reported | not reported | not reported |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/evlv/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $78.5m | 13,537,113 |  | Added +2,000,590 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $42.2m | 7,284,475 |  | Added +200,840 |
| [Stoic Point Capital Management LLC](/funds/2043279.md) | 2026-06-30 | $37.6m | 6,479,298 |  | Added +713,791 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $34.8m | 6,002,387 |  | Added +202,126 |
| [D. E. Shaw & Co., Inc.](/funds/1009207.md) | 2026-06-30 | $28.1m | 4,846,031 |  | Added +3,157,264 |
| [Data Collective IV GP, LLC](/funds/1664974.md) | 2026-06-30 | $26.6m | 4,590,000 |  | Unchanged |
| [TWO SIGMA INVESTMENTS, LP](/funds/1179392.md) | 2026-06-30 | $26.1m | 4,499,208 |  | Reduced −1,468,013 |
| [EMERALD ADVISERS, LLC](/funds/1015083.md) | 2026-06-30 | $24.5m | 4,227,336 |  | Reduced −105,719 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $23.2m | 4,000,222 |  | Added +360,173 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $22.0m | 3,789,950 |  | Added +321,144 |

## Recent filings

[All 549 filings](/companies/evlv/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-11 | 20:57 ET | [10-Q](/filings/0001805385-26-000049.md) | Quarterly report, period 2026-06-30 | 0001805385-26-000049 |
| 2026-08-11 | 20:08 ET | [8-K](/filings/0001805385-26-000047.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001805385-26-000047 |
| 2026-08-10 | 12:00 ET | [8-K](/filings/0001805385-26-000040.md) | 8.01 Other events | 0001805385-26-000040 |
| 2026-06-22 | 21:06 ET | [8-K](/filings/0001805385-26-000036.md) | 5.07 Shareholder vote results | 0001805385-26-000036 |
| 2026-05-13 | 19:12 ET | [8-K](/filings/0001805385-26-000032.md) | 9.01 Financial statements and exhibits | 0001805385-26-000032 |
| 2026-05-12 | 20:15 ET | [10-Q](/filings/0001805385-26-000028.md) | Quarterly report, period 2026-03-31 | 0001805385-26-000028 |
| 2026-05-12 | 20:06 ET | [8-K](/filings/0001805385-26-000027.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001805385-26-000027 |
| 2026-04-30 | 20:07 ET | [DEF 14A](/filings/0001805385-26-000018.md) | Proxy statement, period 2026-06-18 | 0001805385-26-000018 |
| 2026-03-10 | 20:09 ET | [10-K](/filings/0001805385-26-000012.md) | Annual report, period 2025-12-31 | 0001805385-26-000012 |
| 2026-03-10 | 20:07 ET | [8-K](/filings/0001805385-26-000011.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001805385-26-000011 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001805385-26-000012.md), filed Mar 10, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/7f46c9b6-463b-4886-95a5-8587fced0cd7)

## About the filer

- CIK: 1805385
- Tickers: EVLV
- Exchange: Nasdaq
- SIC code: 3577 Computer Peripheral Equipment, NEC
- State of incorporation: not reported
- Filer category: Non-accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:48 ET. No prices; not investment advice.